Dengue: An Overview of Pathogenesis and Analysis of Disease
Dengue: An Overview of Pathogenesis and Analysis of Disease
DOI:
https://doi.org/10.54393/fbt.v1i02.10Keywords:
Dengue, infection, virusAbstract
Dengue as a viral infection was or is a serious issue. With the time this viral infection changes within it’s environment. Researches are conducted to completely know the genome of dengue as well as it’s long lasting treatment. Both flaviviruses and mammalian cells produce NS1 and induce strong humoral responses in circulation. NS1 levels correlate with viral titer and can be used as a viremia marker. The disappearance of NS1 at high concentrations between low nanograms per milliliter and micrograms per milliliter was determined using numerical ELISA detection. NS1 levels as high as 600 nanograms per milliliter during secondary infection have been found to indicate high levels of severe disease within his first 72 hours of illness
References
Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. New England Journal of Medicine. 2012 Apr 12; 366(15): 1423-32. doi: 10.1056/NEJMra1110265
Gupta N, Srivastava S, Jain A, Chaturvedi UC. Dengue in india. The Indian journal of medical research. 2012 Sep; 136(3): 373.
Shakespeare T, Ndagire F, Seketi QE. Triple jeopardy: disabled people and the COVID-19 pandemic. The Lancet. 2021 Apr; 397(10282): 1331-3. doi: 10.1016/S0140-6736(21)00625-5
Chao DL, Halstead SB, Halloran ME, Longini IM. Controlling dengue with vaccines in Thailand. PLoS neglected tropical diseases. 2012 Oct; 6(10): e1876. doi: 10.1371/journal.pntd.0001876
Dayrit MM, Mendoza RU, Valenzuela SA. The importance of effective risk communication and transparency: lessons from the dengue vaccine controversy in the Philippines. Journal of Public Health Policy. 2020 Sep; 41: 252-67. doi: 10.1057/s41271-020-00232-3
Besednova NN, Zaporozhets TS, Andryukov BG, Ermakova SP, Kuznetsova TA, Kryzhanovsky SP, et al. Hemorrhagic fevers: antiviral effects and molecular targets of biologically active polysaccharides and lectins from marine aquatic organisms. Antibiotics and Chemotherapy . 2022; 67(3-4): 53-69. doi: 10.37489/0235-2990-2022-67-3-4-53-69
Cruz-Oliveira C, Freire JM, Conceição TM, Higa LM, Castanho MARB, Da Poian AT. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiology Review. 2015; 39(2): 155-70. doi: 10.1093/femsre/fuu004
Alvarez DE, Lodeiro MF, Luduena SJ, Pietrasanta LI, Gamarnik AV. Long-range RNA-RNA interactions circularize the dengue virus genome. Journal of virology. 2005 Jun; 79(11): 6631-43. doi: 10.1128/JVI.79.11.6631-6643.2005
Jaglan A, Satija S, Singh D, Phartyal R, Verma M. Intra-genomic heterogeneity in CpG dinucleotide composition in dengue virus. Acta Tropica. 2022 Aug; 232: 106501. doi: 10.1016/j.actatropica.2022.106501
Huy NT, Van Giang T, Thuy DH, Kikuchi M, Hien TT, Zamora J, et al. Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS neglected tropical diseases. 2013 Sep; 7(9): e2412. doi: 10.1371/journal.pntd.0002412
Ortiz A, Capitan Z, Mendoza Y, Cisneros J, Moreno B, Zaldivar Y, et al. Simple, specific molecular typing of dengue virus isolates using one-step RT-PCR and restriction fragment length polymorphism. Journal of virological methods. 2012 Oct; 185(1): 129-35. doi: 10.1016/j.jviromet.2012.06.016
Zhao H, Zhao L, Jiang T, Li X, Fan H, Hong W, et al. Isolation and characterization of dengue virus serotype 2 from the large dengue outbreak in Guangdong, China in 2014. Science China Life Sciences. 2014 Dec; 57: 1149-55. doi: 10.1007/s11427-014-4782-3
Su CC, Wu TZ, Chen LK, Yang HH, Tai DF. Development of immunochips for the detection of dengue viral antigens. Analytica chimica acta. 2003 Mar; 479(2): 117-23. doi: 10.1016/S0003-2670(02)01529-5
Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, et al. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio. 2013 Dec; 4(6): e00873-13. doi: 10.1128/mBio.00873-13
Subedi D and Taylor-Robinson AW. Laboratory diagnosis of dengue infection: current techniques and future strategies. Open Journal of Clinical Diagnostics. 2014 Feb; 2014. doi: 10.4236/ojcd.2014.41012
Neumann PW, Weber JM, Jessamine AG, O'shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. Journal of clinical microbiology. 1985 Aug; 22(2): 296-8. doi: 10.1128/jcm.22.2.296-298.1985
Kurane I, Meager A, Ennis FA. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. The Journal of experimental medicine. 1989 Sep; 170(3): 763-75. doi: 10.1084/jem.170.3.763
O’Sullivan P. Diagnosis and classification of chronic low back pain disorders: maladaptive movement and motor control impairments as underlying mechanism. Manual therapy. 2005 Nov; 10(4): 242-55. doi: 10.1016/j.math.2005.07.001
Kittigul L, Meethien N, Sujirarat D, Kittigul C, Vasanavat S. Comparison of dengue virus antigens in sera and peripheral blood mononuclear cells from dengue infected patients. Asian Pacific Journal of Allergy and Immunology. 1997 Dec; 15(4).
Kassim FM, Izati MN, TgRogayah TA, Apandi YM, Saat Z. Use of dengue NS1 antigen for early diagnosis of dengue virus infection. Southeast Asian J Trop Med Public Health. 2011 May; 42(3): 562-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Futuristic Biotechnology
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@fbtjournal.com